Coagulation abnormalities in SARS-CoV-2 infection — pathogenesis and clinical approach
DOI:
https://doi.org/10.52692/1857-0011.2021.1-69.32Keywords:
coagulopathy, anticoagulantsAbstract
Even from the first months after the detection of the novel SARS-CoV-2 virus, coagulation abnormalities have been a distinctive feature of this respiratory infection. During the evolution of the pandemic a bulk of data, some of them contradictory, on the pathogenesis and clinical management of this COVID-19 associated coagulopathy have been emerged. in the present paper we review most relevant data on this topic published at the presentDownloads
Published
Issue
Section
License
Copyright (c) 2021 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.